Azitra, Inc. (AZTR)
0.1716
0.00 (0.00%)
USD |
NYAM |
Sep 21, 16:00
0.1716
0.00 (0.00%)
After-Hours: 20:00
Azitra Shareholders Equity (Quarterly) : 7.334M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.334M |
| March 31, 2026 | 10.48M |
| December 31, 2025 | 3.801M |
| September 30, 2025 | 2.279M |
| June 30, 2025 | 2.229M |
| March 31, 2025 | 4.408M |
| December 31, 2024 | 5.698M |
| Date | Value |
|---|---|
| September 30, 2024 | 8.058M |
| June 30, 2024 | 1.726M |
| March 31, 2024 | 4.324M |
| December 31, 2023 | 2.913M |
| September 30, 2023 | 5.332M |
| June 30, 2023 | 7.236M |
| March 31, 2023 | -3.859M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 113.59M |
| Exicure, Inc. | 0.977M |
| Century Therapeutics, Inc. | 232.34M |
| Absci Corp. | 246.13M |
| Celularity, Inc. | -38.06M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.916M |
| Total Liabilities (Quarterly) | 1.582M |
| Debt to Equity Ratio | 0.0559 |
| Current Ratio | 4.863 |
| Net Debt Paydown Yield | 0.13% |